Page 2 - Abbott

Abbott's stent withdrawal plea rejected

NPPA asks company to prove superiority and then fix higher price

Seven years after Piramal deal, Abbott way off revenue target

It acquired the formulations business from Piramals in 2010 in a $3.7-bn deal

Abbott decides to withdraw 2 stent types from India

These are Alpine drug-eluting stent and Absorb dissolving stent

Abbott's fully absorbable stent under the lens of Indian regulator

Reports suggest that late scaffold thrombosis was higher in the case of Abbot's Absorb stent

Abbott plans to launch device that can detect traumatic brain injury

It's designed to collect blood samples and test protein level in blood to assess extent of injury

Abbott likely to withdraw high-end stents

Any drug brought under price control can be withdrawn after providing 6-month notice to NPPA

Abbott: Real-life stories put the spotlight on health

A new 360-degree campaign by drug maker Abbott features television and radio ads urging people to live each day fully

Abbott India names Ambati Venu as its MD

Venu will be based out of Mumbai and report to Bhasker Iyer, Vice President, Established Pharmaceuticals Division

Abbott India Q1 net up 10% at Rs 74 crore

Shares of Abbott India on Friday closed at Rs 4,731.45 on BSE, up 0.62 per cent from the previous close

Merger agreement with Abbott on: Alere CEO

The two companies had signed an agreement of merger estimated at $5.8 billion

Medicines had expired by the time we got regulator's alert: Abbott

No analytical testing was possible on the expired batch of the epilepsy drug, Mazetol SR 200, Abbott said

Abbott India says to comply with government order on drugs ban

India banned 344 drug combinations after a govt panel of experts found they had 'no therapeutic justification'

Abbott India says to comply with government order on drugs ban

India has banned 344 drug combinations after a govt panel of experts found they had no 'therapeutic justification'